Crossref
Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort
Portuguese Journal of Dermatology and Venereology · 12.11.2026
DOI: 10.24875/pjdv.26000088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portuguese Journal of Dermatology and Venereology, online erschienen am 12.11.2026. Verfasst von Ana Ferreirinha und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ferreirinha, A., Duarte, B., Fialho, M. C., & Simões-Farinha, P. (2026). Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort. Portuguese Journal of Dermatology and Venereology. https://doi.org/10.24875/pjdv.26000088
Vancouver
Ferreirinha A, Duarte B, Fialho MC, Simões-Farinha P. Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort. Portuguese Journal of Dermatology and Venereology. 2026. doi:10.24875/pjdv.26000088
BibTeX
@article{Ferreirinha2026,
author = {Ferreirinha, Ana and Duarte, Bruno and Fialho, Ma. Cristina and Simões-Farinha, Pedro},
title = {Lebrikizumab for difficult-to-treat atopic dermatitis in a Portuguese cohort},
journal = {Portuguese Journal of Dermatology and Venereology},
year = {2026},
doi = {10.24875/pjdv.26000088}
}
EUVIMED